{"id":4107,"date":"2021-03-16T12:41:04","date_gmt":"2021-03-16T11:41:04","guid":{"rendered":"https:\/\/blogs.bmj.com\/medical-ethics\/?p=4107"},"modified":"2021-03-16T12:41:04","modified_gmt":"2021-03-16T11:41:04","slug":"valuing-the-care-in-healthcare-priorities-and-trade-offs","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/","title":{"rendered":"Valuing the care in healthcare: priorities and trade-offs"},"content":{"rendered":"

By Jonathan Michaels.<\/p>\n

Healthcare decisions are complex, whether we are considering individual choices about our own health, or policy decisions made by political or professional bodies.\u00a0 Disease and the actions taken to prevent, diagnose and treat it, may have widespread ramifications on all aspects of our lives.\u00a0 Furthermore, policy and personal decisions in other aspects of our life, may have significant individual or public health implications.\u00a0 These effects have been starkly highlighted by the current pandemic, where we have seen the widespread effects of disease and its management, not only on health outcomes, but on the economy<\/a>, employment <\/a>and personal freedoms<\/a>.\u00a0 Politicians have told us that they are \u201cfollowing the science<\/a>\u201d, but it is clear from the diversity of responses <\/a>that they are making different trade-offs, which may reflect divergent ethical and philosophical responses to the situation.<\/p>\n

About a year ago, I wrote a paper on the potential for epistemic injustices in evidence-based healthcare policy<\/a>, that highlighted some of the potential issues, biases and distortions that may undermine the legitimacy of evidence-based decisions.\u00a0 However, this is only half the story.\u00a0 Even with the best evidence to predict the consequences of our decisions, we are still faced with value judgements about the trade-offs between different processes and outcomes.\u00a0 My current paper was written at about the same time, before the pandemic hit, and addresses some of these value judgments.\u00a0 If I was writing it today, I would have many examples from the different approaches to the health and economic challenges that the pandemic presents.<\/p>\n

In their responses to the pandemic, we have heard politicians variously describing saving lives<\/a>, preserving jobs<\/a>, reopening schools<\/a> or other activities as their \u2018top priority\u2019.\u00a0 Priority is a comparative term, but we rarely hear that such-and-such is a priority over x, y or z.\u00a0 It is easy enough to state that all sorts of things are top priorities if we are not asked to specify what they are being prioritised over.\u00a0 If everything is prioritised, then nothing is a priority.<\/p>\n

In practice, we constantly make trade-offs between the many aspects of our life that we value, whether this is accepting the risks of a surgical procedure to relieve the pain of arthritis, or accepting the risks of car travel, to preserve our freedom of movement.\u00a0 In time, we may learn to live with the pandemic as we do with flu<\/a>, admitting that there is a level of mortality that is an acceptable trade-off against our personal freedoms, our social life and the health of the economy.\u00a0 We may each have a different perspective on such trade-offs.\u00a0 The debate over the timing of second vaccine doses highlights such differences.\u00a0 A public health approach may find that the greater good is served by using limited vaccine supplies to provide single doses to a greater number, delaying the second dose<\/a>, while doctors with individual patient\u2019s interests at heart, may call for the shorter delay<\/a>, evaluated in trials.<\/p>\n

We value many aspects of our life that may be affected by healthcare decisions.\u00a0 In making decisions we must decide whose values and preferences are relevant and how these should be elicited and incorporated.\u00a0 Those making policy decisions in healthcare have widely adopted the quality adjusted life year<\/a> (QALY) as a metric that combines the various dimensions of health with the length of survival.\u00a0 However, this does not capture all the relevant aspects of health outcomes, let alone all the other effects that might be relevant to such decisions.\u00a0 A number of \u2018value assessment frameworks<\/a>\u2019 have been suggested that incorporate other potential consequences of disease, disability and healthcare in the decision-making process.<\/p>\n

In this paper<\/a>, I argue that such frameworks may privilege the interests of certain commercial or political interests that influence their development and adoption.\u00a0 The identified elements of value tend to be those that favour new, high cost, drugs and technologies, and many run the risk of double counting or inflating the apparent value of certain technologies.\u00a0 This is likely to result in decisions that fail to incorporate other features of healthcare that are highly valued by society, particularly those relating to care processes.\u00a0 Valued aspects that are most likely to be displaced are those such as dignity, compassion, choice and autonomy, all of which may have significant resource implications but are more difficult to quantify.<\/p>\n

If we are to develop healthcare policy that reflects societal values and achieves distributive justice, then more attention is required to identify all the aspects of healthcare that we value and ensure that we do not produce procedural mechanisms that result in their displacement by costly new technologies.<\/p>\n

 <\/p>\n

Paper title: Value assessment frameworks: who is valuing the care in healthcare?<\/a><\/p>\n

Author: Jonathan Michaels<\/p>\n

Affiliations: School of Health and Related Research, University of Sheffield<\/p>\n

Competing interests: None<\/p>\n

Social media accounts of post author(s): @JonM_ScHARR<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

By Jonathan Michaels. Healthcare decisions are complex, whether we are considering individual choices about our own health, or policy decisions made by political or professional bodies.\u00a0 Disease and the actions taken to prevent, diagnose and treat it, may have widespread ramifications on all aspects of our lives.\u00a0 Furthermore, policy and personal decisions in other aspects […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":353,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2143,8070],"tags":[],"class_list":["post-4107","post","type-post","status-publish","format-standard","hentry","category-distributive-justice","category-pandemic"],"yoast_head":"\nValuing the care in healthcare: priorities and trade-offs - Journal of Medical Ethics blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valuing the care in healthcare: priorities and trade-offs - Journal of Medical Ethics blog\" \/>\n<meta property=\"og:description\" content=\"By Jonathan Michaels. Healthcare decisions are complex, whether we are considering individual choices about our own health, or policy decisions made by political or professional bodies.\u00a0 Disease and the actions taken to prevent, diagnose and treat it, may have widespread ramifications on all aspects of our lives.\u00a0 Furthermore, policy and personal decisions in other aspects [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/\" \/>\n<meta property=\"og:site_name\" content=\"Journal of Medical Ethics blog\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-16T11:41:04+00:00\" \/>\n<meta name=\"author\" content=\"Mike King\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mike King\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2021\\\/03\\\/16\\\/valuing-the-care-in-healthcare-priorities-and-trade-offs\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2021\\\/03\\\/16\\\/valuing-the-care-in-healthcare-priorities-and-trade-offs\\\/\"},\"author\":{\"name\":\"Mike King\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#\\\/schema\\\/person\\\/b107957622bc42b2097d15e5e02a112c\"},\"headline\":\"Valuing the care in healthcare: priorities and trade-offs\",\"datePublished\":\"2021-03-16T11:41:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2021\\\/03\\\/16\\\/valuing-the-care-in-healthcare-priorities-and-trade-offs\\\/\"},\"wordCount\":810,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#organization\"},\"articleSection\":[\"Distributive justice\",\"Pandemic\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2021\\\/03\\\/16\\\/valuing-the-care-in-healthcare-priorities-and-trade-offs\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2021\\\/03\\\/16\\\/valuing-the-care-in-healthcare-priorities-and-trade-offs\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2021\\\/03\\\/16\\\/valuing-the-care-in-healthcare-priorities-and-trade-offs\\\/\",\"name\":\"Valuing the care in healthcare: priorities and trade-offs - Journal of Medical Ethics blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#website\"},\"datePublished\":\"2021-03-16T11:41:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2021\\\/03\\\/16\\\/valuing-the-care-in-healthcare-priorities-and-trade-offs\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2021\\\/03\\\/16\\\/valuing-the-care-in-healthcare-priorities-and-trade-offs\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/2021\\\/03\\\/16\\\/valuing-the-care-in-healthcare-priorities-and-trade-offs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Valuing the care in healthcare: priorities and trade-offs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/\",\"name\":\"Journal of Medical Ethics blog\",\"description\":\"A blog to discuss the ethics of medicine in its many guises and formats.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#organization\",\"name\":\"Journal of Medical Ethics blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/files\\\/2026\\\/04\\\/jme-logo.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/files\\\/2026\\\/04\\\/jme-logo.png\",\"width\":200,\"height\":50,\"caption\":\"Journal of Medical Ethics blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/#\\\/schema\\\/person\\\/b107957622bc42b2097d15e5e02a112c\",\"name\":\"Mike King\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8caa7ddd85361ccfd46160d9dd41e9ff9aadde6fd8379b80c066d095d69f9f7b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8caa7ddd85361ccfd46160d9dd41e9ff9aadde6fd8379b80c066d095d69f9f7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8caa7ddd85361ccfd46160d9dd41e9ff9aadde6fd8379b80c066d095d69f9f7b?s=96&d=mm&r=g\",\"caption\":\"Mike King\"},\"sameAs\":[\"https:\\\/\\\/www.otago.ac.nz\\\/bioethics\\\/people\\\/academic\\\/profile\\\/index.html?id=774\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/medical-ethics\\\/author\\\/mking\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valuing the care in healthcare: priorities and trade-offs - Journal of Medical Ethics blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/","og_locale":"en_US","og_type":"article","og_title":"Valuing the care in healthcare: priorities and trade-offs - Journal of Medical Ethics blog","og_description":"By Jonathan Michaels. Healthcare decisions are complex, whether we are considering individual choices about our own health, or policy decisions made by political or professional bodies.\u00a0 Disease and the actions taken to prevent, diagnose and treat it, may have widespread ramifications on all aspects of our lives.\u00a0 Furthermore, policy and personal decisions in other aspects [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/","og_site_name":"Journal of Medical Ethics blog","article_published_time":"2021-03-16T11:41:04+00:00","author":"Mike King","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mike King","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/"},"author":{"name":"Mike King","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#\/schema\/person\/b107957622bc42b2097d15e5e02a112c"},"headline":"Valuing the care in healthcare: priorities and trade-offs","datePublished":"2021-03-16T11:41:04+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/"},"wordCount":810,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#organization"},"articleSection":["Distributive justice","Pandemic"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/","url":"https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/","name":"Valuing the care in healthcare: priorities and trade-offs - Journal of Medical Ethics blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#website"},"datePublished":"2021-03-16T11:41:04+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/2021\/03\/16\/valuing-the-care-in-healthcare-priorities-and-trade-offs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/medical-ethics\/"},{"@type":"ListItem","position":2,"name":"Valuing the care in healthcare: priorities and trade-offs"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#website","url":"https:\/\/blogs.bmj.com\/medical-ethics\/","name":"Journal of Medical Ethics blog","description":"A blog to discuss the ethics of medicine in its many guises and formats.","publisher":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/medical-ethics\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#organization","name":"Journal of Medical Ethics blog","url":"https:\/\/blogs.bmj.com\/medical-ethics\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/medical-ethics\/files\/2026\/04\/jme-logo.png","contentUrl":"https:\/\/blogs.bmj.com\/medical-ethics\/files\/2026\/04\/jme-logo.png","width":200,"height":50,"caption":"Journal of Medical Ethics blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/medical-ethics\/#\/schema\/person\/b107957622bc42b2097d15e5e02a112c","name":"Mike King","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/8caa7ddd85361ccfd46160d9dd41e9ff9aadde6fd8379b80c066d095d69f9f7b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8caa7ddd85361ccfd46160d9dd41e9ff9aadde6fd8379b80c066d095d69f9f7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8caa7ddd85361ccfd46160d9dd41e9ff9aadde6fd8379b80c066d095d69f9f7b?s=96&d=mm&r=g","caption":"Mike King"},"sameAs":["https:\/\/www.otago.ac.nz\/bioethics\/people\/academic\/profile\/index.html?id=774"],"url":"https:\/\/blogs.bmj.com\/medical-ethics\/author\/mking\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/posts\/4107","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/users\/353"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/comments?post=4107"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/posts\/4107\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/media?parent=4107"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/categories?post=4107"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/medical-ethics\/wp-json\/wp\/v2\/tags?post=4107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}